Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 84 of the 84 references it cites were found in a registry or an index.

Cardiovascular disease risk factor responses to a type 2 diabetes care model including nutritional ketosis induced by sustained carbohydrate restriction at 1 year: an open label, non-randomized, controlled study

Open access

Published version of a preprint

Abstract

Background: Cardiovascular disease (CVD) is a leading cause of death among adults with type 2 diabetes mellitus (T2D). We recently reported that glycemic control in patients with T2D can be significantly improved through a continuous care intervention (CCI) including nutritional ketosis. The purpose of this study was to examine CVD risk factors in this cohort. Methods: We investigated CVD risk factors in patients with T2D who participated in a 1 year open label, non-randomized, controlled study. The CCI group (n = 262) received treatment from a health coach and medical provider. A usual care (UC) group (n = 87) was independently recruited to track customary T2D progression. Circulating biomarkers of cholesterol metabolism and inflammation, blood pressure (BP), carotid intima media thickness (cIMT), multi-factorial risk scores and medication use were examined. A significance level of P < 0.0019 ensured two-tailed significance at the 5% level when Bonferroni adjusted for multiple comparisons. Results: The CCI group consisted of 262 participants (baseline mean (SD): age 54 (8) year, BMI 40.4 (8.8) kg m −2 ). Intention-to-treat analysis (% change) revealed the following at 1-year: total LDL-particles (LDL-P) (− 4.9%, P = 0.02), small LDL-P (− 20.8%, P = 1.2 × 10 −12 ), LDL-P size (+ 1.1%, P = 6.0 × 10 −10 ), ApoB (− 1.6%, P = 0.37), ApoA1 (+ 9.8%, P < 10 −16 ), ApoB/ApoA1 ratio (− 9.5%, P = 1.9 × 10 −7 ), triglyceride/HDL-C ratio (− 29.1%, P < 10 −16 ), large VLDL-P (− 38.9%, P = 4.2 × 10 −15 ), and LDL-C (+ 9.9%, P = 4.9 × 10 −5 ). Additional effects were reductions in blood pressure, high sensitivity C-reactive protein, and white blood cell count (all P < 1 × 10 −7 ) while cIMT was unchanged. The 10-year atherosclerotic cardiovascular disease (ASCVD) risk score decreased − 11.9% (P = 4.9 × 10 −5 ). Antihypertensive medication use was discontinued in 11.4% of CCI participants (P = 5.3 × 10 −5 ). The UC group of 87 participants [baseline mean (SD): age 52 (10) year, BMI 36.7 (7.2) kg m −2 ] showed no significant changes. After adjusting for baseline differences when comparing CCI and UC groups, significant improvements for the CCI group included small LDL-P, ApoA1, triglyceride/HDL-C ratio, HDL-C, hsCRP, and LP-IR score in addition to other biomarkers that were previously reported. The CCI group showed a greater rise in LDL-C. Conclusions: A continuous care treatment including nutritional ketosis in patients with T2D improved most biomarkers of CVD risk after 1 year. The increase in LDL-cholesterol appeared limited to the large LDL subfraction. LDL particle size increased, total LDL-P and ApoB were unchanged, and inflammation and blood pressure decreased. Trial registration Clinicaltrials.gov: NCT02519309. Registered 10 August 2015

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s12933-018-0698-8

Cites

84 of 84 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Change in biomarkers for CCI group. Bars indicate CCI group mean percent change in biomarkers based on the intention-to-treat analysis with missing values imputed. Percent change is computed as the change in mean values from baseline to 1 year divided by the mean baseline value. Percent change = 100 × [(1 year value − baseline value)/(baseline value)]. Negative values indicate a decrease from baseline to 1 year while positive values indicate an increase. The ** symbol after the biomarker label indicates a statistically significant within group change from baseline (P < 0.0019, P adjusted for multiple comparisons). Error bars represent ± SE. SE as Percent = 100 × [(1 year value SE)/(baseline value)]
Fig. 1 Change in biomarkers for CCI group. Bars indicate CCI group mean percent change in biomarkers based on the intention-to-treat analysis with missing values imputed. Percent change is computed as the change in mean values from baseline to 1 year divided by the mean baseline value. Percent change = 100 × [(1 year value − baseline value)/(baseline value)]. Negative values indicate a decrease from baseline to 1 year while positive values indicate an increase. The ** symbol after the biomarker label indicates a statistically significant within group change from baseline (P < 0.0019, P adjusted for multiple comparisons). Error bars represent ± SE. SE as Percent = 100 × [(1 year value SE)/(baseline value)]CC BY · PubMed Central
Fig. 2 Change in biomarkers for UC group. Bars indicate UC group mean percent change in biomarkers based on the intention-to-treat analysis with missing values imputed. Percent change is computed as the change in mean values from baseline to 1 year divided by the mean baseline value. Percent change = 100 × [(1 year value − baseline value)/(baseline value)]. Negative values indicate a decrease from baseline to 1 year while positive values indicate an increase. (None of the within group changes were statistically significant, i.e. all P > 0.0019, P adjusted for multiple comparisons.) Error bars represent ± SE. SE as Percent = 100 × [(1 year value SE)/(baseline value)]
Fig. 2 Change in biomarkers for UC group. Bars indicate UC group mean percent change in biomarkers based on the intention-to-treat analysis with missing values imputed. Percent change is computed as the change in mean values from baseline to 1 year divided by the mean baseline value. Percent change = 100 × [(1 year value − baseline value)/(baseline value)]. Negative values indicate a decrease from baseline to 1 year while positive values indicate an increase. (None of the within group changes were statistically significant, i.e. all P > 0.0019, P adjusted for multiple comparisons.) Error bars represent ± SE. SE as Percent = 100 × [(1 year value SE)/(baseline value)]CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

3 more claims about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 84 references

Research works printed but not linked: 1

  1. Centers for Disease Control and Prevention (CDC). National diabetes statistics report, 2017. Atlanta: Centers for Disease Control and Prevention; 2017. p. 1–20.

Cited by

See all 190

Metadata

Authors
Bhanpuri, N. H., Hallberg, S. J., Williams, P. T., McKenzie, A. L., Ballard, K. D., Campbell, W. W., McCarter, J. P., Phinney, S. D., & Volek, J. S.
Affiliations
  • Indiana University Health (US)
  • Miami University (US)
  • Purdue University West Lafayette (US)
  • Washington University in St. Louis (US)
  • The Ohio State University (US)
Corresponding author
Bhanpuri, Nasir H.
Venue
Cardiovascular Diabetology
Published
2018-05-01
Volume
17
Issue
1
Pages
56-56
ISSN
1475-2840 (ISSN-L)
OpenAlex
W2802155106
Cited by
190
References
84
Citations by year
2026: 10 · 2025: 15 · 2024: 13 · 2023: 19 · 2022: 33 · 2021: 28 · 2020: 43 · 2019: 23 · 2018: 6
FWCI
17.15
Type
journal article
Language
en
Open access
Licence
Locations
  • Cardiovascular Diabetology (publishedVersion, cc-by)
  • bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion)
  • Europe PMC (PubMed Central) (publishedVersion, other-oa)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Digital Commons@Becker (Washington University School of Medicine) (submittedVersion, cc-by)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
Virta Health
Topics
  • Health Sciences › Medicine › Physiology (medical) › Diet and metabolism studies
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
Keywords
type 2 diabetes, cardiovascular risk factors, nutritional ketosis, carbohydrate restriction, LDL particle size, ApoB/ApoA1 ratio, triglyceride to HDL cholesterol ratio, carotid intima-media thickness, blood pressure, C-reactive protein, inflammation, cholesterol metabolism, health coaching, glycemic control, LDL cholesterol lowering, cardiovascular risk
MeSH terms
Adult, Blood Glucose, Blood Pressure, Cardiovascular Diseases, Combined Modality Therapy, Diabetes Mellitus, Type 2, Diet, Diabetic, Female, Humans, Hypoglycemic Agents, Indiana, Lipids, Male, Middle Aged, Nutritional Status, Prospective Studies, Risk Factors, Time Factors, Biomarkers, Diabetic Ketoacidosis, Treatment Outcome, Inflammation Mediators, Delivery of Health Care, Integrated, 3-Hydroxybutyric Acid, Diet, Carbohydrate-Restricted

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Cardiovascular disease risk factor responses to a type 2 diabetes care model including nutritional ketosis induced by sustained carbohydrate restriction at 1 year: an open label, non-randomized, controlled study. https://app.cochat.ai/papers/10.1186/s12933-018-0698-8
The paper
Bhanpuri, N. H., Hallberg, S. J., Williams, P. T., McKenzie, A. L., Ballard, K. D., Campbell, W. W., McCarter, J. P., Phinney, S. D., & Volek, J. S. (2018). Cardiovascular disease risk factor responses to a type 2 diabetes care model including nutritional ketosis induced by sustained carbohydrate restriction at 1 year: an open label, non-randomized, controlled study. Cardiovascular Diabetology. https://doi.org/10.1186/s12933-018-0698-8

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.